Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
4.000
-0.090 (-2.20%)
At close: May 4, 2026, 4:00 PM EDT
4.100
+0.099 (2.49%)
After-hours: May 4, 2026, 7:55 PM EDT
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $283.72 million as of May 4, 2026. Its market cap has increased by 206.28% in one year.
Market Cap
283.72M
Enterprise Value
77.41M
1-Year Change
206.28%
Ranking
Category
Stock Price
$4.00
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $283.72M, a decrease of -51.70%. That is a compound annual growth rate of -11.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 283.72M | 224.58% |
| Dec 31, 2025 | 87.41M | -59.52% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NervGen Pharma | 305.92M |
| AC Immune | 295.62M |
| Protara Therapeutics | 287.73M |
| C4 Therapeutics | 284.93M |
| Editas Medicine | 283.83M |
| Cellectis | 283.24M |
| Eledon Pharmaceuticals | 280.32M |
| Foghorn Therapeutics | 279.41M |